Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Calvez

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Antiviral Therapy|February 22, 2000
Stavudine resistance: an update on susceptibility following prolonged therapyP F Lin, C J González, B Griffith, et al.
HIV Medicine|September 17, 2004
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapyP Bossi, G Peytavin, H Ait-Mohand, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 17, 2019
Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in MaliM Sylla, O Dolo, A I Maiga, et al.
HIV Medicine|December 12, 2001
MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabineC Katlama, J L Pellegrin, D Lacoste, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2014
High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in MaliD B Fofana, C Soulié, A Baldé, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2018
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencingT Nguyen, D B Fofana, M P Lê, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2015
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTS Lambert-Niclot, E C George, A Pozniak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 15, 2018
Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinantC Soulie, L Morand-Joubert, J Cottalorda, et al.
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
HIV Medicine|January 15, 2015
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort dataJ Vingerhoets, V Calvez, P Flandre, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Antiviral Therapy|February 22, 2000
Stavudine resistance: an update on susceptibility following prolonged therapyP F Lin, C J González, B Griffith, et al.
HIV Medicine|September 17, 2004
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapyP Bossi, G Peytavin, H Ait-Mohand, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|July 17, 2019
Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in MaliM Sylla, O Dolo, A I Maiga, et al.
HIV Medicine|December 12, 2001
MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabineC Katlama, J L Pellegrin, D Lacoste, et al.
The Journal of Antimicrobial Chemotherapy|May 24, 2014
High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in MaliD B Fofana, C Soulié, A Baldé, et al.
The Journal of Antimicrobial Chemotherapy|June 7, 2018
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencingT Nguyen, D B Fofana, M P Lê, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2015
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTS Lambert-Niclot, E C George, A Pozniak, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 15, 2018
Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinantC Soulie, L Morand-Joubert, J Cottalorda, et al.
Journal of Virus Eradication|February 20, 2016
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected childrenP Palma, C Foster, P Rojo, et al.
HIV Medicine|January 15, 2015
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort dataJ Vingerhoets, V Calvez, P Flandre, et al.
Pageof 15